The largest database of trusted experimental protocols

Molm 13 cell line

Manufactured by Leibniz Institute DSMZ
Sourced in Germany

The MOLM-13 cell line is a human acute myeloid leukemia (AML) cell line derived from a patient with AML. The cell line is commonly used in research for the study of AML and related hematological malignancies.

Automatically generated - may contain errors

3 protocols using molm 13 cell line

1

Characterization of AML Cell Lines and Primary Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human AML cell lines U937, KG-1 and MV4-11 were obtained from the American Type Culture Collection (Manassas, VA). The OCI/AML3 cell line was kindly provided by Dr. M. Minden (Princess Margaret Hospital, Toronto, Ontario, Canada). The MOLM13 cell line was obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany). U937, KG-1, MOLM13, and OCI/AML3 cells were validated in September 2010 by short tandem repeat DNA fingerprinting using the AmpFlSTR Identifier kit according to manufacturer’s instructions (Applied Biosystems). Genetic characteristics of AML cell lines used in this study are summarized in Supplementary Table 1.
Peripheral blood and bone marrow samples were obtained from patients with newly diagnosed, relapsed, or refractory AML after written informed consent had been obtained from each patient according to institutional guidelines of the University of Texas, MD Anderson Cancer Center. All cells, including those obtained from peripheral blood and bone marrow samples, were cultured in RPMI 1640 culture medium supplemented with 10% fetal calf serum.
+ Open protocol
+ Expand
2

AML Cell Line Cultivation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
AML cell lines MV-4-11 and THP-1 were purchased from the American Type Culture Collection (Manassas, VA). The MOLM-13 cell line was purchased from Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany). ATCC and DSMZ cell lines are authenticated by short tandem repeat profiling and cytochrome C oxidase gene analysis. Cells were used for the experiments presented here within 10-30 passages from thawing. MV-4-11 cell line was grown in IMDM, and all other cell lines were cultured in RPMI and supplemented with 10-20% fetal bovine serum and 100 U/mL penicillin and 100 ug/mL streptomycin. Cells were kept at 37°C in a 5% CO 2 incubator.
+ Open protocol
+ Expand
3

Decitabine Treatment of Leukemia Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines HL-60 and U937 were obtained from American Type Culture Collection (Rockville, MD, USA). MOLM-13 cell line was obtained from Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). HL-60, U937 and MOLM-13 cell lines were cultured in RPMI-1640 medium supplemented with L-glutamine, 1% Penicillin-Streptomycin and 10% (v/v) fetal bovine serum in a humidified 5% CO2 incubator at 37 °C. Decitabine solution was freshly prepared for each experiment by dissolving decitabine powder in PBS (1X, pH 7.4) at a concentration of 1.00 mM.
For each 1 × 106 cells of HL-60 and U937 cell lines, the dosages of decitabine added to the culture media are 0.00, 0.100, 0.500, 1.00, or 10.0 μM; and were treated for 24 h and 48 h at 37 °C in a humidified 5% CO2 incubator. MOLM-13 cells (1 × 106 cells) was treated with 0.500 μM of decitabine or an equal volume of PBS (1X, pH 7.4) as control for 0, 4, 8, and 24 h at 37 °C in a humidified 5% CO2 incubator. After treatment, the cells were removed from the medium by centrifugation at 1,500 × g, 4 °C for 5 min; and washed twice with 5.00 mL of PBS (1X, pH 7.4) each. The cell pellets were collected and stored in −20 °C until DNA extraction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!